Physician profile
Hardeep Singh
NPI 1104876127
$5,486.82
in general payments reported to CMS, 2019-2025
39 companies · $666 in 2025
The $666 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $320 · 2021: $493 · 2022: $1,288 · 2023: $1,148 · 2024: $900 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,519 · Travel and Lodging: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,519.26 |
| Travel and Lodging | $195.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,782.78 | 2019-2025 | Linzess, Skyrizi, Viberzi |
| Takeda Pharmaceuticals U.S.A., INC. | $444.55 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $373.97 | 2023-2025 | Caplyta |
| Alphatec Spine, INC | $323.79 | 2022-2023 | |
| Stryker Corporation | $291.93 | 2023-2024 | Core, Cascadia Interbody System |
| Janssen Biotech, INC. | $212.69 | 2019-2023 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $194.70 | 2019-2023 | Xifaxan |
| Cook Medical LLC | $169.41 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $133.39 | 2024 | Iqirvo |
| Intuitive Surgical, INC. | $125.54 | 2025 | |
| Celgene Corporation | $114.60 | 2022-2023 | Zeposia |
| Pfizer INC. | $111.07 | 2019-2025 | |
| Lundbeck LLC | $109.20 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $96.57 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $91.30 | 2021-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hardeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.